PepTalk 2017
PepTalk 2017
Pipeline Six Header

Cambridge Healthtech Institute’s Sixth Annual
Higher-Throughput Protein Production and Characterization
Innovating Processes
January 12-13, 2017 | Hilton San Diego Bayfront | San Diego, CA

High-throughput processes have transformed the traditional protein-by-protein trial-and-error approach for testing criteria and scaling up. In this leading Higher-Throughput Protein Production and Characterization conference, HTP will be explored in the quest to develop methods that ensure quality and translate to large scale. Automation, robotics and liquid handlers will be discussed, along with developing small-scale models that shed light on bioproduction. Case studies will be presented that illustrate how leaders in the field are integrating HTP approaches in order to reduce the time and effort needed to successfully analyze proteins, fine-tune processes, and achieve well-folded, pure protein.

Preliminary Agenda  



KEYNOTE PRESENTATION: Scale-Down Models for High-Throughput Chromatography of Proteins

Alois Jungbauer, Ph.D., Professor, Laboratory of Protein Technology and Downstream Processing, Austrian Center of Biotechnology, Biotechnology, University of Natural Resources and Life Sciences (BOKU)

Automation Solutions for Different Stages of Protein Purification Process Development

Jean Aucamp, Ph.D., Principal Scientist, Technology Development, Novel Biological Entities, Novartis Pharma AG

Multistage Purification of Human Antibodies for Candidate Selection using an Automated Liquid Handler Platform that Enables High Throughput and High Recovery
Louis Fabri, Director, Protein Technologies, CSL Pharmaceuticals


Applying Synthetic Biochemistry and High-Throughput Processes to Enable Bugs to Make Drugs

Andrew Fosberry, Ph.D., Manager, Expression and Fermentation Sciences, GlaxoSmithKline

HTP Production of the Human PDZ Repertoire, Identification and Ranking of the PDZ Interacting with the Human Papillomavirus E6 Oncoprotein

Renaud Vincentelli, Ph.D., Head, Protein Production, Structural Biology Facility, CNRS Univ Aix Marseille I & II

Using High-Throughput Techniques to Produce Difficult Targets: Flavivirus NS1, an Updated Case Study 

William Clay Brown, Ph.D., Associate Research Scientist and Scientific Director, High-Throughput Protein Lab, Center for Structural Biology/Life Sciences Institute, University of Michigan 



High-Throughput Methods for the Characterization of Relevant Protein Features

Jonas V. Schaefer, Ph.D., Head, High-Throughput Binder Selection Facility, Biochemistry, University of Zurich

High-Throughput Biophysical and Biochemical Stability Screening for Early Stage Antibody Discovery

Yingda Xu, Ph.D., Associate Director, Protein Analytics, Adimab LLC


A Miniaturized Process Chain Representing the Entire Downstream Process for Inclusion Bodies

Cornelia Walther, Ph.D., Scientist, Biotechnology, University of Natural Resources and Life Sciences (BOKU)

High-Throughput Manufacturability Assessment of Complex Biologics

Zhenyu Gu, Ph.D., Development Scientist III, Early Assay Development, Alexion Pharmaceuticals


For questions about the meeting, please contact:

Mary Ruberry
Senior Conference Director
Cambridge Healthtech Institute
Phone: 781-972-5421

For partnering & sponsorship information, please contact:

Companies A-K
Jason Gerardi
Manager, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5452
Fax: 781-972-5470

Companies L-Z
Carol Dinerstein
Director, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5471
Fax: 781-972-5470